BioCardia, Inc. Quarterly Depreciation in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BioCardia, Inc. quarterly/annual Depreciation history and growth rate from Q1 2016 to Q3 2024.
  • BioCardia, Inc. Depreciation for the quarter ending September 30, 2024 was $16K, a 23.8% decline year-over-year.
  • BioCardia, Inc. Depreciation for the twelve months ending September 30, 2024 was $72K, a 10% decline year-over-year.
  • BioCardia, Inc. annual Depreciation for 2023 was $84K, a 2.44% increase from 2022.
  • BioCardia, Inc. annual Depreciation for 2022 was $82K, a 36.7% increase from 2021.
  • BioCardia, Inc. annual Depreciation for 2021 was $60K, a 11.8% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $72K $16K -$5K -23.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $77K $17K -$4K -19% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $81K $19K -$3K -13.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $84K $20K +$4K +25% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $80K $21K -$8K -27.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $88K $21K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $88K $22K +$6K +37.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $82K $16K +$1K +6.67% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $81K $29K +$14K +93.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $67K $21K +$5K +31.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $62K $16K +$2K +14.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $60K $15K +$6K +66.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $54K $15K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $54K $16K -$6K -27.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $60K $14K -$8K -36.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $68K $9K -$24K -72.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $92K $15K -$14K -48.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $106K $22K -$4K -15.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $110K $22K -$1K -4.35% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $111K $33K +$11K +50% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $100K $29K +$7K +31.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $93K $26K +$4K +18.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $89K $23K +$1K +4.55% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $88K $22K +$1K +4.76% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-09
Q3 2018 $87K $22K +$1K +4.76% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 $86K $22K -$1K -4.35% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $87K $22K +$9K +69.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $78K $21K +$12K +133% Oct 1, 2017 Dec 31, 2017 10-K 2020-04-09
Q3 2017 $66K $21K +$12K +133% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $54K $23K +$12K +109% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $42K $13K +$3K +30% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $39K $9K Oct 1, 2016 Dec 31, 2016 10-K 2019-04-02
Q3 2016 $9K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $11K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $10K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.